Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer, KRAS G12C

Bob T. Li

MD, PhD, MPH

🏢Memorial Sloan Kettering Cancer Center🌐USA

Medical Oncologist and Associate Attending Physician

47
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Bob T. Li is a thoracic oncologist at MSK specializing in molecularly targeted therapy for NSCLC. He has been a co-investigator in multiple KRAS G12C inhibitor trials and has worked extensively on ctDNA monitoring in KRAS-mutant lung cancer. His research also spans HER2-targeted therapies and rare driver oncogenes in lung cancer.

Share:

🧪Research Fields 研究领域

KRAS G12C lung cancer
HER2-mutant lung cancer
liquid biopsy
targeted therapy NSCLC
pan-tumor KRAS

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Bob T. Li 的研究动态

Follow Bob T. Li's research updates

留下邮箱,当我们发布与 Bob T. Li(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment